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Viruses that establish latent infection must maintain their DNA in the host nucleus through many cellular generations. Here
we identify a novel mechanism by which the gammaherpesvirus Kaposi’s sarcoma-associated herpesvirus (KSHV) may
achieve this persistence in latently infected body cavity-based lymphoma (BCBL) cells. We find that KSHV genomic DNA is
associated with host chromosomes and colocalizes with the latency-associated nuclear antigen (LANA). Furthermore, a
region at the left end of the KSHV genome binds strongly to LANA and can colocalize to the host chromosomes with LANA.
Additionally, we found that LANA associates with histone H1 in KSHV-infected BCBL cells. We propose that this chromosomal
association of the KSHV genome is mediated by LANA and involves a tethering mechanism by which viral episomes are
linked to host chromatin through simultaneous interaction with host chromosomal proteins including histone H1 and
cis-acting KSHV DNA elements. This strategy may be employed by other viruses in establishment of latency in the infected
cells. © 1999 Academic Press
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wIntroduction. Kaposi’s sarcoma was initially de-
cribed by Moritz Kaposi as a multifocal vascular tu-
or affecting elderly men of Mediterranean or Eastern
uropean origin. More recently, this neoplasm has
ecome prevalent in immunocompromised patients,
uch as transplant recipients on immunosuppressive
herapy and AIDS patients, and it has become one of
he leading common cancers among AIDS patients (1).
he relationship of the disease to geography and
mmunocompromised patients led to the suspicion of
n infectious agent in Kaposi’s sarcoma pathogenesis.
his suspicion was supported when Kaposi’s sarco-
a-associated herpesvirus (KSHV)2 or human herpes-
irus 8 (HHV8) was identified through PCR-based stud-
es of tumor samples from AIDS patients with Kaposi’s
arcoma (2). Subsequent studies have shown that the
irus is of the Gammaherpesviridae family, bearing
equence similarity to herpesvirus saimiri (HVS) and
pstein–Barr virus (EBV) (3). Although there is increas-
ng epidemiologic data associating the virus with hu-
1 To whom correspondence and reprint requests should be ad-
ressed. Fax: (734) 764-3562. E-mail: esrobert@umich.edu.
2 Abbreviations used: KSHV, Kaposi’s sarcoma-associated herpesvi-
us; HHV8, human herpesvirus 8; IP, immunoprecipitation; FISH, fluo-
escence in situ hybridization; EBV, Epstein–Barr virus; EBNA, Epstein–farr virus nuclear antigen; BCBL, body cavity-based lymphomas.
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254an disease, little is known about the biology of this
ew gammaherpesvirus.
Indirect immunofluorescence studies of the latently
nfected body cavity-based lymphoma (BCBL) cell line
ith serum from Kaposi’s sarcoma (KS) patients reveals
characteristic punctate pattern of nuclear immunoflu-
rescence due to the presence of what was termed the
atency-associated nuclear antigen (LANA) (4). LANA is
etected in the majority of cells in a KS lesion as well as
n cell lines derived from body cavity lymphomas (4, 5).
ANA is encoded by orf73 of KSHV and is expressed as
latency-associated protein in the infected cell (4). An
nalysis of the LANA amino acid sequence reveals sev-
ral acidic and proline/glutamine-rich regions as well as
zinc finger DNA-binding domain (6, 7). These structural
otifs suggest that LANA may act as a transcription
actor; however, it is possible that like EBNA1, LANA may
e involved in maintenance of the viral episome in in-
ected cells. LANA appears to be consistently detected
n KSHV-infected cells and may be one of only a few
SHV proteins expressed in the latently infected cell (5,
). Therefore the ability of LANA to support persistence
f the KSHV genome may be a crucial function in the
stablishment of latency. Little is known regarding the
echanism and establishment of KSHV latency. In this
eport we have investigated the possible mechanism by
hich LANA supports KSHV persistence in latently in-ected cells.
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255RAPID COMMUNICATIONResults. LANA and KSHV episomes localize to host
etaphase chromosomes in a similar pattern in KSHV-
nfected cells. To determine whether LANA has a role in
SHV DNA persistence analogous to EBNA1 in EBV we
onducted fluorescence in situ hybridization (FISH) and
mmunofluorescence studies to detect viral DNA and
ANA protein on the metaphase chromosomes. Viral
osmids were used as probes on metaphase chromo-
omes prepared from a KSHV-positive/EBV-negative cell
ine, BC-3 (9), derived from a body cavity lymphoma and
he EBV- and KSHV-negative B cell line BJAB was used
s a control. Analysis of nuclei from BC-3 cells with the
SHV cosmid probe showed a punctate pattern through-
ut the nucleus consistent with greater than 30 epi-
omes for each nucleus examined (Fig. 1a). Similarly,
hen nuclei from KSHV-infected BC-3 were stained with
ntibodies against LANA and detected by FITC-conju-
ated secondary antibodies a punctate pattern was also
bserved throughout the nuclei (Fig. 1b). These results
ndicated that LANA and KSHV could be associated with
he host metaphase chromosomes. Metaphase spreads
ere then prepared from BC-3 cells and stained as
efore with KSHV-labeled cosmid probe and human se-
um recognizing LANA. Although viral DNA was detected
n symmetrical patterns achieved by replication of a
hromatid to which virus has integrated, it was not con-
istently seen from one spread to another, suggesting
hat the signal was associated with the host chromo-
omes in a random fashion (Fig. 1d). Furthermore, when
imilar chromosome spreads derived from the same
SHV-positive BC-3 cells were probed with a human
erum adsorbed with B cell antigens that preferentially
ecognize LANA (Fig. 1e), LANA signals localized to the
ost metaphase chromosomes in a pattern strikingly
imilar to that of KSHV-specific DNA hybridization (com-
are Figs. 1d and 1e). This chromosome-associated pat-
ern of immunofluorescence was not evident in meta-
hase spreads probed with normal human serum from a
SHV-negative adult patient, previously adsorbed with B
ell antigens from an EBV-negative cell line, BJAB, as
ell as an EBV-positive line, B958 (Fig. 1f). Additionally,
o signal was observed with KSHV cosmid probe on
etaphase spreads from KSHV- and EBV-negative BJAB
hromosomes (Fig. 1c). This suggests that the signal is
pecific for LANA and is not due to a nonspecific signal
rom the polyclonal human serum (compare Figs. 1e and
f). Therefore LANA and KSHV are both associated with
hromosomes, which is consistent with the notion that
ANA may have a function in maintaining KSHV DNA in
he infected cells. Moreover, these results also indicate
hat LANA may have the ability to bind to specific se-
uences on the KSHV genome and can potentially colo-
alize with the KSHV genome on the metaphase
preads. rLANA displays preferential binding to different regions
f KSHV DNA in vitro. To ascertain whether LANA had
he capacity to bind specific sequences in KSHV DNA,
32P]dCTP-radiolabeled probes spanning the viral ge-
ome (Fig. 2b) were incubated with in vitro translated
ANA–myc fusion protein, followed by immunoprecipita-
ion with anti-myc antibodies. To detect probes specifi-
ally bound to LANA, immunoprecipitates were quanti-
ied by liquid scintillation counting. Binding of LANA to
NA was expressed as a percentage of total probe
oimmunoprecipitated with LANA–myc (Fig. 2b shows a
chematic of the regions of KSHV used in this assay).
he results of this experiment, shown in Fig. 2a (left
anel) demonstrated that LANA most preferentially
ound a region of the KSHV genome referred to as Z6,
ocated within the first 34 kb at the left end of the viral
enome (3). Figure 2a is representative of the mean of
eparate experiments in which Z6 bound to LANA–myc
ore favorably than other regions of the KSHV genome.
nterestingly, the unique region Z8 in the middle of the
iral genome and Z2 also bound, albeit less preferentially
o the immunoprecipitated Z6–LANA–myc complex (Fig.
a). Similar to EBNA 1, an EBV protein important for
aintenance of EBV episomes, LANA may bind several
ifferent sites in the KSHV genome, suggesting multiple
unctional roles of LANA in KSHV latent infection (10–13).
We then further analyzed Z6 for identifying a more
ocalized region within this large molecule by digesting
he cosmid with NotI to release the insert followed by
igestion with BamHI for the left 10-kb NotI fragment and
partial HindIII for the right NotI 24-kb fragment of Z6.
he resulting five fragments were then labeled and
ound to LANA–myc. The mean of counts of duplicate
xperiments from the immunoprecipitation plotted in Fig.
a (right panel) revealed that a fragment containing the
erminal repeats and a region of approximately 1.8 kbp
rom the left end of the genome within Z6 gave the
trongest binding activity. This binding activity was ap-
roximately 5- to 10-fold greater than the rest of the Z6
ragments (see Fig. 2a, right panel). These results
trongly indicate that the potential cis-acting DNA ele-
ent mediating LANA binding to the KSHV genome and
o tethering the KSHV genome to the chromosome may
ie within a short span of KSHV DNA approximately 1.8 kb
t the left end of the KSHV genome and one copy of the
erminal repeat. It should be noted that other regions of
he genome do bind with relative affinity to LANA, indi-
ating the potential for a multifunctional role for LANA.
urther work is under way to investigate the binding to
hese other regions and the potential for additional roles
f LANA.
LANA and KSHV DNA colocalize to metaphase chro-
osomes in KSHV infected cells. To determine whether
ANA can colocalize with KSHV DNA, metaphase chro-
osome spreads were generated from cells prepared byeducing the time of fixing to only 1 h but maintaining the
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257RAPID COMMUNICATIONtringent washes in the DNA hybridization step. This
etains chromosome-associated proteins that would be
ost by the typical overnight fixation used in standard
ISH protocols but keeps the stringency of the signal
inimizing nonspecific signals (compare Figs. 1d and 1e
ith Figs. 3b and 3c). These spreads were probed with
FIG. 2. LANA preferentially binds to specific regions of the KSHV ge
32P]dCTP-labeled KSHV DNA probes and then coimmunoprecipitated w
s a ratio of bound DNA to unbound labeled DNA. Z6 binds preferenti
f binding activity. (Right) Z6 insert was purified from vector and then dig
f the fragments that includes a copy of the terminal repeats at the lef
ANA. The results indicate strong binding to a fragment within Z6 loca
b) Schematic depicting location of KSHV cosmid and lambda probes w
lone) (3). Note the location of regions showing preferential binding of L
o LANA. The genome is shown as a long unique region flanked by te
FIG. 3. KSHV DNA colocalizes with LANA to host chromosomes i
hromosome spreads of BC-3 cells were probed with Z6-labeled pro
preads. (a) The representative metaphase chromosome spread for
etection of LANA with anti-LANA immunofluorescence; (c) metaphase
he anti-LANA serum merged on the same metaphase chromosome de
hromosomes hybridized with the Z6-specific KSHV DNA probe, follow
ignals from the KSHV probe and anti-LANA antibodies tightly colocaliz
ell line BC-3 (20). All metaphase chromosome spreads were analyzed
icroscope.SHV DNA and amplified via a tyramide-based fluoro-
hrome deposition (NEN Life Sciences) for increased
ensitivity, followed immediately by anti LANA immuno-
luorescence in an effort to colocalize viral DNA and
ANA protein at host metaphase chromosomes. When
oth signals from the KSHV probe and the anti-LANA
(a) In vitro translated LANA–myc fusion proteins were incubated with
i-myc antibody (9E10 from ATCC). Extent of DNA binding is expressed
ANA; however, Z8 as well as Z2 also demonstrated significant levels
into subfragments with BamHI (left 10 kb) and HindIII (right 24 kb). One
f the genome and four other subfragments in Z6 were incubated with
he left end of the genome that includes a copy of the terminal repeat.
he 140-kb KSHV genome (Z denotes cosmid clone, L denotes lambda
ithin the Z6 cosmid. Z6TR indicates a region with the strongest affinity
repeats similar to members of the gammaherpesvirus family (7).
cells. (a–d) BC-3 colocalization of LANA and Z6 probe. Metaphase
anti-LANA antibody showing specific staining on the chromosome
ocalization experiment stained with DAPI. (b) Metaphase spread for
s for detection of KSHV DNA. (d) Signals from both the DNA probe and
ating colocalization at the same positions. (a–d) The BC-3 metaphase
nti-LANA immunofluorescence and DAPI counterstaining. (d) Specific
st chromosomes in the latently infected body cavity-based lymphoma
03 original magnification with fluorescent filters on an Olympus AX70nome.
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258 RAPID COMMUNICATIONntibody were superimposed it became evident that both
ignals colocalize to the chromosomes in BC-3 (Fig. 3d).
preads of BJAB cells did not result in any specific signal
s before in Figs. 1d and 1e (data not shown). The
bservation that no signal was seen in the BJAB spreads
ndicated that the signals seen in BC-3 are specific for a
SHV-encoded or a KSHV-induced cellular protein and is
ost likely due to that of the latency-associated antigen
ince the polyclonal human serum used was previously
dsorbed with B cell as well as EBV-infected B cell
ntigens, therefore increasing the specificity for the
SHV latent antigen LANA (3, 4). These results strongly
uggest that LANA and KSHV DNA can colocalize to the
ost metaphase chromosome in the KSHV-infected BC-3
ells. Moreover, we have shown that LANA binds pref-
rentially to regions of the KSHV genome. Therefore it
ould be interesting to determine whether these regions
an be targeted to the metaphase chromosomes in the
resence of LANA.
Cis-acting DNA elements in Z6 plus LANA are suffi-
ient for chromosomal localization in BJAB transfected
ells. The previous data provided the basis for further
xperiments in which we tested the hypothesis that re-
ions of KSHV DNA that display preferential binding to
ANA may contain cis-acting elements that can cooper-
te with LANA to confer chromosome localization of the
SHV genome. BJAB cells were cotransfected with Z6 or
8 cosmid DNA along with an expression plasmid con-
truct of the LANA–myc fusion protein under the control
f the CMV IE promoter. Immuno-FISH analysis was then
arried out on these cells, using the appropriate cosmids
hat were transfected as probes followed by immunoflu-
rescence with anti-myc monoclonal antibody to improve
pecificity for detection of the LANA–myc protein not
btained with the polyclonal human sera. Analysis of
hese transfected cells revealed the colocalization of Z6
ut not Z8 viral DNA with LANA to the host chromosomes
Figs. 4a–4c and 4j–4l). Furthermore, this colocalization
as dependent on the presence of LANA protein, as the
ame probe did not localize to host chromosomes when
otransfected with empty myc vector (Figs. 4d–4f). The
umber of signals seen in these spreads was less than
hat seen in Figs. 1a and 1b where multiple DNA and
rotein signals were seen. We elected to increase the
tringency of washes to minimize nonspecific associa-
ions frequently seen in these assays. These data indi-
ate that LANA and cis-acting elements in Z6 are suffi-
ient for chromosome localization of KSHV DNA. Further-
ore, while Z8 appeared to display a significant affinity
or LANA protein in the in vitro binding assay (see Fig.
a), this interaction did not result in chromosomal local-
zation. Additionally, LANA did not localize to the chro-
osomes itself, suggesting a requirement for a complex
o stabilize KSHV and LANA to the host chromosomes. In
hese experiments approximately 20% of the cells were
sually transfected and in screening the prepared chro- dosome spreads 5–10% had signals for KSHV DNA. In
he spreads where positive signals were seen with
SHV, LANA signals were also seen in every instance.
owever, no signal was seen with Z8 or LANA in Z8 plus
ANA transfected cells although LANA was expressed in
ll BJAB transfected cells. These results may indicate a
onsequence of LANA’s ability to bind regions of the
SHV genome outside of the maintenance origin and
ould be potentially involved in transcription or other
egulatory events required for the long-term survival of
SHV in the infected cell.
LANA interacts with the nucleosome-associated his-
one H1 linker protein. The results of these experiments
rompted us to hypothesize that LANA tethers KSHV
pisomes through interactions with cis-acting elements
t Z6 to host chromosomes potentially through its asso-
iation with chromosomal proteins. Therefore, coimmu-
oprecipitation experiments were conducted to deter-
ine whether LANA specifically interacts with nucleo-
ome-associated histone proteins that could allow for a
iochemical mechanism by which the KSHV genome is
ethered to host chromosomes. Initially, histone H1 was
hosen since we hypothesized that H1 would be more
asily accessible to tethering than the core histones H2,
3, and H4, which would be tightly bound within the
hromatin structure. Immunoprecipitates generated from
estern blot analysis of anti-H1 immunoprecipitates us-
ng anti-LANA polyclonal human serum (Fig. 5a) revealed
222- to 234-kDa band comigrating in lysate and immu-
oprecipitation lanes in BC-1 and BC-3 but not in the
SHV-negative BJAB cells (compare lanes 1 and 3 with
anes 4 and 6 and lanes 7 and 9 in Fig. 5a). This result
uggests association of LANA with linker histone H1 in
SHV-infected cells. Similarly, Western blot for LANA
rom immunoprecipitates with anti-H3 and -H4 antibod-
es indicated that no specific signal for LANA was seen
y Western blot. These results suggest that LANA may
e associated with the chromosome linker histone and
ot the core histones.
To determine whether LANA can interact directly with
istone H1 we performed an in vitro experiment in which
n vitro translated LANA–myc tagged protein was incu-
ated with crude histone extracts and immunoprecipi-
ated with anti-myc antibodies. The immunoprecipitates
ere then fractionated by SDS–PAGE. Anti-H1 Western
lot analysis of these immunoprecipitates revealed a 30-
o 32-kDa doublet in the crude histone input lane (10 mg
f crude histones) comigrating with an identical band in
he histone plus LANA–myc lane, but not in control lanes
here crude histones or LANA alone was immunopre-
ipitated (Fig. 5b). This suggests that LANA interacts
irectly with histone H1 probably through its large acidic
omains (3, 4). It should be noted that Western blots for
3 and H4 from similar in vitro experiments did not show
ny specific signals (data not shown). There is prece-
ence for the H1 association since one previous report
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259RAPID COMMUNICATIONy Sugden and colleagues identified histone H1 as a
arget for EBNA1 in a yeast screen (14). Cumulatively,
hese results support our hypothesis that LANA associ-
tes with histone H1 in the KSHV-infected cells. Given
he acidic nature of the LANA protein (3, 4), it is possible
hat LANA may also interact with other chromosomal
roteins; however, further immunoprecipitation experi-
ents from KSHV-infected cells and with crude nuclear
xtracts using specific antibodies to other nucleosome-
ssociated antigens will prove interesting if LANA asso-
iates with other nucleosome-associated proteins. It is
learly possible that histone H1 may not be the only
FIG. 4. Cis-acting elements within the Z6 but not Z8 regions of the K
NA and LANA to host chromosomes. BJAB cells were cotransfected
g–i). Metaphase chromosomes were prepared from transfected cells a
ollowed by immunofluorescence with an anti-myc antibody specific fo
ANA. (a) DAPI with signal from the Z6 probe, (b) green fluorescence in
he similar probe, Z6, does not localize to metaphase chromosomes in
n the presence of LANA. No signal was seen for LANA, which does n
lement within Z6. It is also possible that LANA expression may be mo
f this experiment, suggesting nonspecific association. This transfectio
n the metaphase chromosome spreads in all fields on multiple slides.
luorescent filters on an Olympus AX70 microscope.hromosomal protein associated with LANA and further oxperiments will have to be done to address associa-
ions with many other chromosome-associated antigens,
s more reagents become available. The ability of his-
one H1 to function as a linker histone (15) could be an
mportant factor in providing the accessibility for LANA to
ether the KSHV genome to the chromosome. These data
learly demonstrates that LANA interacts with histone
1 and associates with H1 in KSHV-infected body cavity-
ased lymphoma cells.
Discussion. Taken together, these data indicate that
he KSHV genome is tethered to the host chromosome
hrough its interactions with LANA. It was further dem-
enome and LANA are sufficient to confer colocalization of KSHV viral
1 LANA-myc (a–c), Z6 1 empty myc vector (d–f), or Z8 1 LANA-myc
ed for the specific KSHV DNA cosmid transfected in each experiment,
-myc. (a–c) The Z6 cosmid localizes to chromatin in the presence of
g LANA–myc signals, and (c) colocalization of Z6 and LANA–myc. (d–f)
sence of LANA. (g–i) Z8 does not localize to metaphase chromosomes
m to target the chromatin structure in the absence of a specific DNA
se in this experiment and was removed during the procedural phase
done multiple times with no positive signal for either Z8 or LANA–myc
mosome spreads were analyzed at 10003 original magnification withSHV g
with Z6
nd prob
r LANA
dicatin
the ab
ot see
re diffu
n was
All chronstrated that LANA binds preferentially to cis-acting
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260 RAPID COMMUNICATIONlements located within the Z6, but also to Z8 and Z2
SHV cosmid probes and that chromatin localization
epends on the presence of both LANA and Z6, but not
8. Further mapping of the binding region within Z6
ndicates that this cis-acting element is located close to
he left end of the KSHV genome. Moreover, the immu-
oprecipitation data show that LANA binds host histone
1 in body cavity-based lymphoma-derived cells and in
rude histone extracts in vitro. This interaction has two
otentially important consequences. First, it provides the
irst biochemical link between KSHV episomes and a
FIG. 5. The KSHV encoded LANA protein interacts with nucleosom
SHV-infected body cavity lymphoma cells BC-1 and BC-3 as demonst
lot with human serum with activity against LANA. Lysates from BJAB
ncubated with monoclonal H1 antibodies, and precipitated by cen
mmunoprecipitates were fractionated by SDS–PAGE and Western blot a
ndicates the position of the 222- to 234-kDa LANA protein seen in the ly
anes (lane 1). LANA was immunoprecipitated in BC-1 and BC-3 cells (la
f immunoprecipitation experiments with anti-H3 and -H4 antibodie
DS–PAGE gel and then transferred to nitrocellulose membrane. Th
olyclonal serum for detection of LANA. As demonstrated LANA signal
ell lines. No signals were seen in the immunoprecipitate lanes in eith
50 mg) were incubated with in vitro translated LANA–myc fusion pro
–Sepharose beads and centrifugation. Immunoprecipitates were fr
embrane followed by Western blot analysis with anti-H1 monoclonal
ane 1 with 10 mg of crude histones; the lower H1 band is comigratin
etected in lane 1 is also seen in lane 4 where LANA–myc and crude his
r LANA–myc was immunoprecipitated with anti-myc monoclonal ant
ranslated LANA–myc alone; H1L, crude histones plus LANA–myc.ost chromatin protein that may thereby confer persis- nence of the KSHV genome in daughter cells. Second,
ecause histone H1 has increasingly been regarded as
modulator of eukaryotic transcription (15), LANA may
nfluence expression of histone H1 transcriptional tar-
ets through modulation of histone H1 transcriptional
ctivities. These interactions lead us to assert a model
escribing a novel mechanism of viral persistence, sum-
arized in Fig. 6. In this model, the KSHV encoded LANA
ethers the KSHV episome to host chromosomes through
nteraction with the linker histone H1 and specific cis-
cting elements located within the Z6 region of the ge-
ociated histone H1 protein. (a) LANA associates with histone H1 in
y immunoprecipitation with anti-H1 monoclonal antibody and Western
, and BC-1 cells were precleared with Protein A–-Sepharose beads,
ion after the addition of more Protein A–Sepharose beads. These
using a polyclonal human serum reactive to LANA. Arrow on the right
ne of BC-1 and BC-3 (lanes 4 and 7) but not in the KSHV-negative BJAB
nd 9) but not in the KSHV negative BJAB cells (lane 3). (Bottom) Results
ate Biotechnology). Immunoprecipitates were fractionated on a 6%
brane containing bound proteins was then incubated with human
early detected in the lysate lanes of the KSHV-infected BC-1 and BC-3
1 or BC-3. (b) LANA interacts with histone H1 in vitro. Crude histones
nd immunoprecipitated with anti-myc antibodies followed by Protein
ted by 10% SDS–PAGE and transferred to a 0.45-mm nitrocellulose
y. Arrows on the left indicates the migration of histone H1 doublet in
immunoglobulin light chain (compare lanes 1 and 4). The H1 signal
re present. No signal was seen in the lanes where only crude histones
input, 10 mg of crude histones; H, crude histones alone; L, in vitroal-ass
rated b
, BC-3
trifugat
nalysis
sate la
nes 6 a
s (Upst
e mem
was cl
er BC-
tein a
actiona
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g with
tones a
ibody. Home. Additional experiments in our laboratory have
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261RAPID COMMUNICATIONndicated that Z2 may also be capable of tethering to host
hromosomes, suggesting a possible cis-acting element
ithin the TR element. However, Z2 contains an unse-
uenced region approximately 3 kbp in size to the ex-
reme right end of the unique sequence (3). Moreover,
ANA also demonstrated some degree of binding to Z8
ut had no ability to tether this fragment of the KSHV to
he host chromosome. This indicates some other poten-
ial functional role of LANA besides the ability to link
SHV to host chromosomes. Further analysis would be
equired to determine the LANA-binding elements within
2 and Z8. These results may shed light on other roles of
ANA in KSHV-infected body cavity-based lymphoma
ells.
A synthesis of data collected over several years re-
eals that such a mechanism of persistent infection may
lso be possible in EBV-infected cells. It is well known
hat EBV episomes and EBNA1 are randomly associated
ith metaphase chromosomes (16). It has long been
hought that EBNA1 was necessary for both viral persis-
ence and replication (12, 13). However, recent studies
trongly suggest that EBNA1 does not recruit the repli-
ative machinery to oriP and may not be required for
eplication (14). EBNA1, however, allows persistence of
riP containing plasmids. Additionally, histone H1 was
dentified in a one-hybrid screen for proteins that interact
FIG. 6. Schematic of a proposed mechanism of persistence in KSHV-
NA elements on the KSHV genome depicted here as LBR (LANA-bind
1 and potentially other as yet unidentified chromosomal proteins.
hromosomes and thereby ensures viral persistence in daughter cells th
trategy utilized by most latent viruses in the infected cell.ith EBNA1 bound to oriP (14). Despite all these data, eolocalization of EBNA1 and EBV to chromosomes as
ell as the biochemical basis of their association with
hromosomes has not been demonstrated.
Sugden and colleagues hypothesized that EBNA1
inds to specific DNA sequences on EBV and links this
ound DNA through its many linking domains by inter-
cting with chromosome-associated proteins (14). LANA
ay exhibit functions analogous to those of EBNA1 in
inking KSHV episomes to host chromosomes, thereby
nsuring control of copy number, segregation, and per-
istence in the infected cell. LANA may also function as
viral defense against host strategies that may have
volved to eliminate viral genetic material, similar to the
ay that EBNA1 prevents overwhelming episomal loss in
BV infection (14).
Here we describe the first specific biochemical mech-
nism by which the KSHV episome is linked or tethered
o the host chromosome through the interaction of LANA
ith histone H1 and possibly other chromosomal pro-
eins with specific cis-acting elements of KSHV DNA. We
uggest that a similar mechanism may exist for the
ersistence of EBV and other latent viruses in infected
ells.
We are currently in the process of finely mapping the
pecific cis-acting DNA elements within the KSHV ge-
ome that confer this chromosomal tethering. Additional
body cavity-based lymphoma cells. LANA binds to specific cis-acting
ion) and simultaneously binds the chromosomal linker protein histone
ssociation allows LANA to tether the KSHV episomal DNA to host
successive rounds of cell division. This mechanism may be a commoninfected
ing reg
This a
roughxperiments will be necessary to determine whether
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262 RAPID COMMUNICATIONhese interactions exist in other latent viruses including
he hepatitis (HBV, HCV) and polyoma (HPV, SV40) fam-
lies and how they may affect viral replication and distri-
ution of viral genomes during mitosis. Furthermore,
hese interactions are potentially multifunctional in that
hey suggest roles in persistence, replication, and tran-
cription. Delineation of the multiple binding regions for
ANA on the KSHV genome may provide clues as to the
ature of the potential multifunctional roles of LANA. It is
lso clear that antagonism of these interactions repre-
ents a novel therapeutic possibility for eradication of
SHV-associated diseases and other viral infections.
Recently, while our work was in review, Ballestas and
olleagues also published a separate report of similar
indings in which LANA was found to colocalize with the
SHV genome in BCBL1-infected cells (17). Therefore
hese findings though independent from each other both
upport the hypothesis that LANA functions in persis-
ence of the KSHV genome in the infected cells.
Materials and methods. Genomic and cDNA clones,
ell culture, and transfection. Cosmid and lambda clones
panning the KSHV genome (Z2, Z6, Z8 and L48, L54,
56, L74, respectively) were obtained from the National
nstitutes of Health, AIDS Research and Reference Re-
gent Program (3). Coordinates for these fragments
closest approximation) are: Z6 from the 59 end of KSHV
o 34,613; L74 from 36,243 to 57,672; L47 from 56,496 to
9,547; L56 from 64,788 to 80,444; Z8 from 74,131 to
09,353; L54 from 121,829 to 137,183, and Z2 from 127,780
o the 39 end of the KSHV genome (James Russo and
atrick Moore, personal communication). ORF73 cDNA
as obtained by polymerase chain reaction amplification
f DNA using Vent DNA polymerase (NEB) from a body
avity lymphoma-derived cell line, BC-1 (9, 18), with the
ollowing primers: 59-GAGAATTCTTATGGCGCCCCCGG-
AATG-39 (sense), 59-GAGATATCCCTGTCATTTCCTGTG-
AGA-39 (antisense). Fragments were purified, digested
ith EcoRI and EcoRV, and cloned into a myc-tagged
xpression vector, pA3M (19). BC-1, BC-3 (9, 18, 20) (ob-
ained from ATCC), and BJAB cells (obtained from Elliott
ieff) were grown in RPMI 1640 (Gibco), supplemented
ith 20% FBS (10% for BJAB), penicillin (25 U/ml), strep-
omycin (25 mg/ml), and gentamicin (10 mg/ml).
For transfections, 15 million BJAB cells were collected
nd transfected with 50 mg KSHV cosmid DNA (Z6 or Z8)
nd 50 mg LANA–myc plasmid cDNA (or myc vector
lone) by electroporation (220 V, 975 mF) in 400 ml of
PMI 1640 supplemented with 10% FBS and then incu-
ated in 10 ml of the medium. After transfection, cells
ere incubated for 24 h and then collected for immuno-
luorescence in situ hybridization and/or Western blot
nalysis.
Fluorescence in situ hybridization analysis. Meta-
hase chromosome spreads for FISH were prepared by
tandard protocols. Briefly, cells were metaphase ar-
ested with colcemid (10 mg/ml, Gibco) for 1 h at 37°C cnd then treated with 0.75 M KCl for 12 min at 37° C,
ollowed by overnight fixation in fresh methanol:acetic
cid (3:1) at 4°C. Cells were spread on slides and al-
owed to age for no less than 72 h. Hybridization was
one overnight at 37°C with a digoxigenin-labeled KSHV
osmid probe and then detected with rhodamine- or
luorescein-conjugated anti-digoxigenin antibodies and
ounterstained with DAPI.
Preparation of metaphase chromosomes for detection
f chromosomal-associated proteins. Chromosome
preads for immunofluorescence were prepared as
bove except that fixation time was shortened to 1 h to
reserve chromosome-associated antigens. Additional
ashing steps were included to minimize nonspecific
ssociations and to retain the specific associations with
he chromosomes. Therefore care was taken to be as
tringent as possible without losing most of the protein
ignals. Slides were blocked in 20% normal goat serum
or 30 min at room temperature, washed in PBS, and
ncubated in human serum reactive to LANA or normal
SHV-negative human serum overnight at 4°C. Slides
ere again washed and then incubated in goat anti-
uman FITC secondary antibody (1:1000) for 1 h at room
emperature. Slides were washed, counterstained with
API, and coverslipped with antifade for fluorescence
icroscopy analysis.
In vitro DNA binding. Cosmids, lambda probes, or
solated DNA fragments of KSHV DNA were radiolabeled
ith [32P]dCTP through a standard nick translation pro-
ocol and separated from unincorporated label with
ucTrap probe purification columns (Stratagene). LANA–
yc protein was generated by in vitro translation of
ANA–myc cDNA with rabbit reticulocyte lysate (Pro-
ega) as per the manufacturer’s suggestions. Three mi-
roliters of protein was incubated with 3 m l labeled
SHV probe at 4°C for 45 min in 50 m l of binding buffer
10% glycerol, 20 mM HEPES (N-2-hydroxyethylpipera-
ine-N-2-ethanesulfonic acid; pH 7.9), 150 mM NaCl, 0.5%
onidet-P40, 250 mg bovine serum albumin per milliliter,
mM dithiothreitol, 10 mg of aprotinin per milliliter, 1 mM
henylmethylsulfonyl fluoride, 1 mM leupeptin, 1 mM
epstatin) (19). Simultaneously, 25 ml Protein G–Sepha-
ose beads were incubated with 50 ml monoclonal anti-
yc antibody (supernatant from 9E10 hybridoma cells) in
50 ml binding buffer rotating at 4°C for 45 min (19).
ound DNA protein complexes were added to prebound
b–Protein G–Sepharose complexes and incubated for
5 min with continued rotation at 4°C. Complexes were
hen collected by centrifugation at 15,000 rpm for 1 min at
°C in a microcentrifuge. Precipitates were washed
wice by removal of supernatant, resuspended in 200 ml
inding buffer as above, and centrifuged in a microcen-
rifuge. Supernatants from washes were pooled and
ounted in a liquid scintillation counter, as were the
orresponding pellets. DNA bound to LANA protein was
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263RAPID COMMUNICATIONhen calculated as a fraction of labeled DNA in the pellet
ver the labeled DNA in the supernatant.
Preparation of metaphase chromosomes for im-
uno-FISH double-labeling. Metaphase chromosome
preads for immuno-FISH colocalization were pre-
ared as above with a 1-h fixation period to preserve
hromosome-associated antigens. Hybridization was
one overnight at 37°C with a biotinylated KSHV cos-
id or lambda probe and then detected with a direct
yramide–rhodamine signal amplification system (NEN
ife Sciences), according to the manufacturer’s sug-
estions. This system increases the sensitivity by am-
lification of the signals at the site deposited, allowing
or detection of very low signals. After repeated
ashes to remove the nonspecific signals the slides
ere subjected to the immunofluorescence protocol
s described above. Slides were washed, counter-
tained with DAPI, and coverslipped with antifade for
luorescence microscopy analysis.
Immunoprecipitation and in vitro binding. BC-1, BC-3,
r BJAB cells were lysed in RIPA buffer and precleared
y incubation with Protein A–Sepharose as previously
escribed. Immunoprecipitates were generated with
onoclonal H1 antibodies (2 m g/ml; Upstate Biotech-
ology), washed four times in RIPA buffer, fractionated
y SDS–PAGE, and transferred to 0.45-mm nitrocellu-
ose membranes. Western blots were performed with
uman serum reactive to LANA at a 1:500 dilution and
tandard chemiluminescence detection protocols
Amersham). For in vitro binding experiments, 50 mg of
rude histones (type II-A, Sigma) were incubated with
0 ml of in vitro translated LANA–myc fusion protein for
h at 4°C. Complexes were precipitated by the addi-
ion of anti-myc antibodies and Protein G–Sepharose
eads followed by centrifugation. Immunoprecipitates
ere fractionated by SDS–PAGE and transferred to
itrocellulose membranes for Western blot analysis
ith monoclonal H1 antibodies.
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